Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - ROTECH HEALTHCARE INC | dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of report (date of earliest event reported) March 10, 2011
Rotech Healthcare Inc.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation) |
000-50940 (Commission File Number) |
030408870 (IRS Employer Identification No.) |
2600 Technology Drive, Suite 300
Orlando, Florida 32804
(Address of principal executive offices Zip Code)
Registrants telephone number, including area code (407) 822-4600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
Rotech Healthcare Inc. (the Company) issued a press release on March 10, 2011. A copy of the Companys press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
All of the information furnished in this report and the accompanying exhibit shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 | Press Release dated March 10, 2011. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
ROTECH HEALTHCARE INC. | ||||
Date: March 10, 2011 | By: | /S/ PHILIP L. CARTER | ||
Philip L. Carter President and Chief Executive Officer |